Cinemark USA, Inc. Reports Results for Fourth Quarter and Fiscal Year 2005.

PLANO, Texas -- Cinemark USA, Inc., one of the leaders in the motion picture exhibition industry, today reported results for the fourth quarter and year ended December 31, 2005.

Cinemark USA, Inc.'s revenues for the fourth quarter ended December 31, 2005 increased 6.9% to $273.6 million from $256.0 million for the fourth quarter ended December 31, 2004. The increase was primarily related to a 6.4% increase in average ticket prices. Operating income for the fourth quarter ended December 31, 2005 was $30.0 million compared with operating income of $34.0 million for the fourth quarter ended December 31, 2004. Earnings before interest, taxes, depreciation, amortization, the Recapitalization Charges and other non-cash expenditures ("Adjusted EBITDA") for the fourth quarter ended December 31, 2005 increased 5.6% to $58.1 million from $55.0 million for the fourth quarter ended December 31, 2004. The Company's Adjusted EBITDA margin was 21.2% for the fourth quarter ended December 31, 2005. Net income for the fourth quarter ended December 31, 2005 was $11.2 million compared to net income of $12.8 million for the fourth quarter ended December 31, 2004.

For the year ended December 31, 2005, revenues decreased 0.4% to $1,020.6 million from $1,024.2 million for the year ended December 31, 2004. The decrease was primarily related to a 7.6% decrease in attendance partially offset by a 7.3% increase in average ticket prices. The Company's operating income for the year ended December 31, 2005 was $119.0 million compared with operating income of $153.9 million for the year ended December 31, 2004, excluding the Recapitalization Charges. Adjusted EBITDA for the year ended December 31, 2005 decreased to $210.6 million from $230.0 million for the year ended December 31, 2004. The Company's Adjusted EBITDA margin was 20.6% for the year ended December 31, 2005. Net income for the year ended December 31, 2005 was $48.4 million compared to net income of $63.8 million for the year ended December 31, 2004, excluding the Recapitalization Charges net of taxes.

Cinemark USA, Inc. continues to be a leader in the development of stadium seating multiplex theatres. During the year ended December 31, 2005, the Company opened 18 new theatres with a total of 172 screens. On December 31, 2005, the Company's aggregate screen count was 3,329, with screens in the United States, Canada, Mexico, Argentina, Brazil, Chile, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Colombia. As of December 31, 2005, the Company had signed commitments to open 16 new theatres with 204 screens during 2006. The Company also had signed commitments to open six new theatres with 60 screens subsequent to 2006.

The Company intends that this press release be governed by the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995 (the "PSLR Act") with respect to statements that may be deemed to be forward-looking statements under the PSLR Act. Such forward-looking statements may include, but are not limited to, the Company and any of its subsidiaries' long-term theatre strategy. Actual results could differ materially from those indicated by such forward-looking statements due to a number of factors.

The Company, headquartered in Plano, TX, has a website at www.cinemark.com where customers can view showtimes and purchase tickets.

Cinemark USA, Inc.
                   Financial and Operating Summary
                      (unaudited, in thousands)

                           Three months ended        Year ended
                              December 31,          December 31,
                           ------------------- -----------------------
                             2005      2004       2005        2004
                           --------- --------- ----------- -----------
Statement of Income data
 (1):

   Theatre revenues        $273,589  $255,952  $1,020,597  $1,024,242

   Film rentals and
    advertising              94,216    87,288     347,727     348,816
   Concession supplies       14,356    13,359      52,507      53,761
   Facility lease expense    35,567    32,430     136,593     126,643
   Other theatre operating
    expenses                 59,133    54,234     225,262     216,050
   General and
    administrative
    expenses                 12,850    14,416      50,722      51,550
   Stock option
    compensation and
    change of control
    expenses related to
    the Recapitalization         --        --          --      31,995
   Depreciation,
    amortization and
    impairment of long-
    lived assets             26,703    18,012      86,133      68,718
   Loss on sale of assets
    and other                   717     2,215       2,625       4,851
                           --------- --------- ----------- -----------
Total costs and expenses    243,542   221,954     901,569     902,384
                           --------- --------- ----------- -----------
Operating Income             30,047    33,998     119,028     121,858

   Interest expense (2)      12,498    11,004      47,108      45,403
   Other (income) expense    (1,819)      (65)     (4,627)      8,455
                           --------- --------- ----------- -----------
Income from continuing
 operations before income
 taxes                       19,368    23,059      76,547      68,000
Income taxes                  8,166    13,204      28,182      27,030
                           --------- --------- ----------- -----------
Income from continuing
 operations                  11,202     9,855      48,365      40,970

Income from discontinued
 operations, net of taxes        --     2,917          --       3,584
                           --------- --------- ----------- -----------
Net income                  $11,202   $12,772     $48,365     $44,554
                           ========= ========= =========== ===========

Other Financial Data (1):
   Adjusted EBITDA (3)      $58,110   $55,023    $210,600    $229,965
   Adjusted EBITDA margin
    (4)                        21.2%     21.5%       20.6%       22.5%

Other Operating Data (1):
   Domestic Attendance
    (patrons)                27,316    28,156     105,573     113,646
   International
    Attendance (patrons)     14,834    13,936      60,104      65,695
                           --------- --------- ----------- -----------
   Worldwide Attendance
    (patrons)                42,150    42,092     165,677     179,341
                           ========= ========= =========== ===========

                                                        As of
                                                    December 31,
Balance Sheet Data:                               2005        2004
                                               ----------- -----------
   Cash and cash equivalents                     $182,180    $100,228
   Theatre properties and equipment, net          790,566     785,595
   Total assets                                 1,097,740   1,001,565
   Long-term debt, including current portion      620,277     626,943
   Shareholder's equity                           251,172     168,835



              Reconciliation of Adjusted EBITDA (unaudited)
                             (in thousands)

                                   Three months        Year ended
                                ended December 31,     December 31,
                                ------------------ -------------------
                                  2005     2004      2005      2004
                                 -------- -------- --------- ---------
Net income                       $11,202  $12,772   $48,365   $44,554
   Income taxes                    8,166   13,204    28,182    27,030
   Interest expense (2)           12,498   11,004    47,108    45,403
   Other (income) expense         (1,819)     (65)   (4,627)    8,456
   Income from discontinued
    operations, net of taxes          --   (2,917)       --    (3,584)
                                 -------- -------- --------- ---------
Operating income                  30,047   33,998   119,028   121,859
   Add:  Depreciation,
    amortization and impairment
    of long-lived assets          26,703   18,012    86,133    68,718
   Add:  Loss on sale of assets
    and other                        717    2,215     2,625     4,851
   Add:  Amortized compensation
    -- stock options (5)              --       --        --       145
   Add:  Deferred lease expenses
    (6)                              643      798     2,814     2,397
   Add:  Stock option
    compensation and change of
    control expenses related to
    the Recapitalization              --       --        --    31,995
                                 -------- -------- --------- ---------
   Adjusted EBITDA (3)           $58,110  $55,023  $210,600  $229,965
                                 ======== ======== ========= =========



(1) Statement of income data, other financial data and other operating
    data exclude the results of the Company's two United Kingdom
    theatres and eleven Interstate theatres for all periods presented,
    as these theatres were sold during 2004. The results of operations
    for these theatres are presented as discontinued operations.

(2) Includes amortization of debt issue costs and excludes capitalized
    interest.

(3) Adjusted EBITDA as calculated in the chart above represents net
    income before income taxes, interest expense, other (income)
    expense, income from discontinued operations, depreciation,
    amortization and impairment of long-lived assets, loss on sale of
    assets and other, accrued and unpaid compensation expense relating
    to any stock option plans, changes in deferred lease expense, and
    stock option compensation and change of control expenses related
    to the Recapitalization. Adjusted EBITDA is a non-GAAP financial
    measure commonly used in our industry and should not be construed
    as an alternative to net income or operating income as an
    indicator of operating performance or as an alternative to cash
    flow provided by operating activities as a measure of liquidity
    (as determined in accordance with GAAP). Adjusted EBITDA may not
    be comparable to similarly titled measures reported by other
    companies. The calculation of Adjusted EBITDA is consistent with
    the definition of EBITDA in our senior subordinated notes
    indentures. We have included Adjusted EBITDA because we believe it
    provides management and investors with additional information to
    measure our performance and liquidity, estimate our value and
    evaluate our ability to service debt. In addition, we use Adjusted
    EBITDA for incentive compensation purposes.

(4) Adjusted EBITDA margin is calculated using Adjusted EBITDA divided
    by revenues.

(5) Non-cash expense included in general and administrative expenses.

(6) Non-cash expense included in facility lease expense.